MX2016007534A - Composicion de gel de acido hialuronico que tiene durabilidad. - Google Patents
Composicion de gel de acido hialuronico que tiene durabilidad.Info
- Publication number
- MX2016007534A MX2016007534A MX2016007534A MX2016007534A MX2016007534A MX 2016007534 A MX2016007534 A MX 2016007534A MX 2016007534 A MX2016007534 A MX 2016007534A MX 2016007534 A MX2016007534 A MX 2016007534A MX 2016007534 A MX2016007534 A MX 2016007534A
- Authority
- MX
- Mexico
- Prior art keywords
- cross
- gel composition
- sustained release
- linked
- hyaluronic acid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/554—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being a steroid plant sterol, glycyrrhetic acid, enoxolone or bile acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6903—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being semi-solid, e.g. an ointment, a gel, a hydrogel or a solidifying gel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/042—Gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/91—Injection
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Botany (AREA)
- Molecular Biology (AREA)
- Pain & Pain Management (AREA)
- Dispersion Chemistry (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Se proporciona una composición de gel polisacárido reticulado usado en cosméticos y campos medicinales, y más en particular, a una composición de gel de ácido hialurónico que tiene durabilidad capaz de mantener la durabilidad durante un largo tiempo dentro de un cuerpo viviente sin incrementar un índice de vinculación de reticulado al incluir un material que tiene funciones de inhibición a la descomposición y antioxidación de polisacárido en gel de polisacárido reticulado. Además, la composición es un complejo de hidrogel en el cual el ácido ursólico se contiene en un polisacárido no reticulado o reticulado.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020130152585A KR101459070B1 (ko) | 2013-12-09 | 2013-12-09 | 지속성을 갖는 히알루론산 겔 조성물 |
PCT/KR2014/011912 WO2015088198A1 (ko) | 2013-12-09 | 2014-12-05 | 지속성을 갖는 히알루론산 겔 조성물 |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2016007534A true MX2016007534A (es) | 2016-12-14 |
Family
ID=52290482
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2016007534A MX2016007534A (es) | 2013-12-09 | 2014-12-05 | Composicion de gel de acido hialuronico que tiene durabilidad. |
Country Status (10)
Country | Link |
---|---|
US (1) | US20170000816A1 (es) |
EP (1) | EP3081232A4 (es) |
JP (1) | JP2016540025A (es) |
KR (1) | KR101459070B1 (es) |
CN (1) | CN105979968A (es) |
BR (1) | BR112016013219A8 (es) |
CA (1) | CA2933153C (es) |
MX (1) | MX2016007534A (es) |
RU (1) | RU2631888C1 (es) |
WO (1) | WO2015088198A1 (es) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101866310B1 (ko) | 2016-05-31 | 2018-06-11 | 주식회사 글랜젠 | 생체 내 지속성 및 항산화 작용이 향상된 진피 충전재 조성물 및 이의 제조방법 |
IT201600079773A1 (it) * | 2016-07-29 | 2018-01-29 | Matteo Bevilacqua | Composizioni contenenti oligosaccaridi di acido ialuronico (HA4), condroitin solfato (CS2-4) ed eparan solfato (HS2-4), triterpeni pentaciclici e derivati per uso medico curativo e metodo per la preparazione di tali composizioni. |
CA3055985A1 (en) | 2017-03-22 | 2018-09-27 | Genentech, Inc. | Hydrogel cross-linked hyaluronic acid prodrug compositions and methods |
KR101845349B1 (ko) | 2017-08-25 | 2018-04-04 | 최명 | 폴리이온 컴플렉스를 포함하는 하이드로겔 생성물 및 이의 제조방법 |
KR20190051434A (ko) | 2017-11-07 | 2019-05-15 | 주식회사 엑소코바이오 | 신규한 히알루론산 기반의 필러 조성물 및 이의 응용 |
KR101856435B1 (ko) * | 2018-02-05 | 2018-06-20 | 동의대학교 산학협력단 | 히알루론산을 포함하는 조직 수복용 조성물 및 이의 제조 방법 |
KR20210017476A (ko) | 2019-08-08 | 2021-02-17 | (주)아모레퍼시픽 | 동결건조 제형 조성물 및 이를 포함하는 피부 외용제 화장품 키트 |
TR201922945A2 (tr) * | 2019-12-31 | 2021-07-26 | Vsy Biyoteknoloji Ve Ilac Sanayi Anonim Sirketi | Osteoartri̇t tedavi̇si̇ i̇çi̇n propoli̇s i̇çeri̇kli̇ yeni̇ bi̇r vi̇skoelasti̇k formülasyonu ve bunun üreti̇m yöntemi̇ |
EP4135772A4 (en) * | 2020-04-17 | 2024-04-24 | Brendan Patrick Purcell | CONTROLLED RELEASE HYALURONIC ACID COMPOSITIONS |
KR102298390B1 (ko) * | 2020-12-02 | 2021-09-03 | 동의대학교 산학협력단 | 히알루론산을 함유하여 우수한 피부 수복효과를 나타내는 조직 수복용 조성물 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1434044A (en) * | 1973-07-17 | 1976-04-28 | Biorex Laboratories Ltd | Immobilised pentacyclic triterpenes |
US4582865A (en) | 1984-12-06 | 1986-04-15 | Biomatrix, Inc. | Cross-linked gels of hyaluronic acid and products containing such gels |
US5827937A (en) | 1995-07-17 | 1998-10-27 | Q Med Ab | Polysaccharide gel composition |
FR2813018B1 (fr) * | 2000-08-21 | 2004-02-06 | Boots Co Plc | Compositions cosmetiques renfermant au moins un compose stimulant la neosynthese des laminines, et/ou de l'integrine alpha-2 beta-1 et/ou du collagene iv de la jonction dermo- epidermique |
JP4822092B2 (ja) * | 2003-09-01 | 2011-11-24 | 大正製薬株式会社 | W/o/w型複合エマルション |
JP2006124322A (ja) * | 2004-10-28 | 2006-05-18 | Takasago Internatl Corp | ヒアルロニダーゼ阻害剤、および該ヒアルロニダーゼ阻害剤を含有する皮膚外用組成物および口腔用組成物 |
JP2007045733A (ja) * | 2005-08-09 | 2007-02-22 | Shiseido Co Ltd | ヒアルロニダーゼ阻害剤 |
JP4716497B2 (ja) * | 2005-08-09 | 2011-07-06 | 株式会社 資生堂 | 皮膚外用剤およびヒアルロニダーゼ阻害剤 |
JP4528745B2 (ja) * | 2006-06-14 | 2010-08-18 | 日光ケミカルズ株式会社 | チロシナーゼ産生抑制剤 |
US20090075935A1 (en) * | 2006-07-03 | 2009-03-19 | L'oreal | Composition comprising at least one c-glycoside derivative and at least one hyaluronic acid and its cosmetic use |
CA2670694A1 (en) * | 2006-11-27 | 2008-11-20 | National Research Council Of Canada | Soft gel formulations |
DE102008050036A1 (de) * | 2007-10-02 | 2009-04-30 | Kuhs Gmbh | Topisch zu applizierende kosmetische oder pharmazeutische Zusammensetzung |
KR100994410B1 (ko) * | 2008-06-03 | 2010-11-16 | 서범구 | 주름 완화 기능을 갖는 피부적용 제제용 하이드로겔 조성물 |
FR2938187B1 (fr) * | 2008-11-07 | 2012-08-17 | Anteis Sa | Composition injectable a base d'acide hyaluronique ou l'un de ses sels, de polyols et de lidocaine, sterilisee a la chaleur |
US20110171310A1 (en) * | 2010-01-13 | 2011-07-14 | Allergan Industrie, Sas | Hydrogel compositions comprising vasoconstricting and anti-hemorrhagic agents for dermatological use |
KR101550941B1 (ko) * | 2010-10-14 | 2015-09-07 | (주)아모레퍼시픽 | 리피드가 코팅된 하이드로겔 입자 및 이의 제조방법 |
JP2013032316A (ja) * | 2011-08-02 | 2013-02-14 | Univ Of Tsukuba | 腎不全の進行抑制用医薬組成物、並びに腎不全の合併症の予防及び治療用医薬組成物 |
KR101428145B1 (ko) * | 2011-11-24 | 2014-08-08 | (주)아모레퍼시픽 | 수불용성 겔 조성물 및 그 제조방법 |
WO2013149323A1 (en) * | 2012-04-02 | 2013-10-10 | Ntegrity | Natural products for skin care |
-
2013
- 2013-12-09 KR KR1020130152585A patent/KR101459070B1/ko active IP Right Grant
-
2014
- 2014-12-05 CA CA2933153A patent/CA2933153C/en active Active
- 2014-12-05 RU RU2016122860A patent/RU2631888C1/ru active
- 2014-12-05 EP EP14869008.4A patent/EP3081232A4/en not_active Withdrawn
- 2014-12-05 US US15/102,818 patent/US20170000816A1/en not_active Abandoned
- 2014-12-05 WO PCT/KR2014/011912 patent/WO2015088198A1/ko active Application Filing
- 2014-12-05 BR BR112016013219A patent/BR112016013219A8/pt not_active IP Right Cessation
- 2014-12-05 MX MX2016007534A patent/MX2016007534A/es active IP Right Grant
- 2014-12-05 CN CN201480075016.7A patent/CN105979968A/zh active Pending
- 2014-12-05 JP JP2016539202A patent/JP2016540025A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2016540025A (ja) | 2016-12-22 |
CN105979968A (zh) | 2016-09-28 |
BR112016013219A8 (pt) | 2018-01-30 |
EP3081232A1 (en) | 2016-10-19 |
WO2015088198A1 (ko) | 2015-06-18 |
US20170000816A1 (en) | 2017-01-05 |
CA2933153C (en) | 2018-07-03 |
EP3081232A4 (en) | 2017-06-14 |
KR101459070B1 (ko) | 2014-11-17 |
RU2631888C1 (ru) | 2017-09-28 |
CA2933153A1 (en) | 2015-06-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2016007534A (es) | Composicion de gel de acido hialuronico que tiene durabilidad. | |
MX2017006232A (es) | Relleno dermico a base de acido hialuronico reticulado y lubricante de carboximetilcelulosa. | |
MX2015009106A (es) | Composiciones de solución sólida y su uso en el tratamiento del dolor intenso. | |
NZ730865A (en) | Peptides having anti-inflammatory properties | |
PH12016500511A1 (en) | Selective grp94 inhibitors and uses thereof | |
EP4299128A3 (en) | Dopa decarboxylase inhibitor compositions | |
MX2015009045A (es) | Composiciones y metodos para tratar el dolor severo. | |
MX2019000902A (es) | Desinfectantes topicos emolientes. | |
MY176334A (en) | Nanogels for delayed gelation | |
BR112015023987A2 (pt) | creme dental de duas fases | |
MX2015015197A (es) | Vendaje para herida que comprende una composicion antimicrobiana. | |
EP3021857A4 (en) | BIOMATERIALS COMPRISING HYALURONIC ACID-BINDING PEPTIDES AND PEPTIDES BINDING TO THE EXTRACELLULAR MATRIX FOR APPLICATIONS ASSOCIATED WITH TISSUE ENGINEERING AND HYALURONIC ACID RETENTION | |
MX2015017273A (es) | Composiciones que comprenden acido hialuronico reticulado y ciclodextrina. | |
AU2018253594A1 (en) | Dihydroxyphenyl neurotransmitter compounds, compositions and methods | |
MX2017012596A (es) | Una composicion farmaceutica y el uso de la misma. | |
MX2018007871A (es) | Composiciones para el cuidado personal. | |
HRP20170198T1 (hr) | Pripravci koji sadrže kondroitin-sulfat, natokinazu i sulfhidrilne spojeve za upotrebu u liječenju upale | |
MX2015017334A (es) | Uso de un polímero de acrilato de 2-octilo como agente de enlace en una composición de recubrimiento. | |
MX2015013187A (es) | Composiciones de anfetamina transdermica estable y metodos de fabricacion. | |
MX2015015952A (es) | Composicion que comprende una combinacion de un polimero acrilico y un copolimero de silicona y un aminoacido o un derivado de aminoacido. | |
EP3059286A4 (en) | Silicone gel composition, and silicone gel cured product | |
CY1122457T1 (el) | Μη πτητικες οφθαλμικες συνθεσεις, ειδικες για τη θεραπεια της ξηροφθαλμιας | |
CO2024003209A2 (es) | Composición adhesiva antimicrobiana con nanopartículas de cobre para prótesis | |
MX2016010229A (es) | Conjugados del factor vii. | |
NZ713440A (en) | Nsaid administration and related compositions, methods and systems. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |